
Relmada Therapeutics, Inc. (NASDAQ:RLMD) Q1 2025 Earnings Name Might 12, 2025 4:30 PM ET
Firm Individuals
Brian Ritchie – Investor Relations
Sergio Traversa – Chief Government Officer
Maged Shenouda – Chief Monetary Officer
Yair Lotan – Chief, Urology and Oncology
Convention Name Individuals
Uy Ear – Mizuho Securities
Matt Barcus – Jefferies
Operator
Good afternoon. Welcome to the Relmada Therapeutics First Quarter 2025 Earnings Name. [Operator Instructions] As a reminder, this convention is being recorded, and will probably be accessible for replay on the placement web site. I want to flip the decision over to Brian Ritchie from LifeSci Advisors. Please go forward, Mr. Ritchie.
Brian Ritchie
Good day and thanks everybody for becoming a member of us as we speak. This afternoon, Relmada issued a press launch offering a enterprise replace and outlining its monetary outcomes for the three months ended March 31, 2025. Please be aware that sure data mentioned on the decision as we speak is roofed beneath the protected harbor provision of the Personal Securities Litigation Reform Act. We warning listeners that in this name, Relmada’s administration workforce will probably be making forward-looking statements.
Precise outcomes may differ materially from these acknowledged or implied by these forward-looking statements on account of dangers and uncertainties related to the corporate’s enterprise. These forward-looking statements are certified by the cautionary statements contained in Relmada’s press launch issued as we speak and the corporate’s SEC filings, together with within the annual report on Type 10-Ok, and as we speak’s kind 10-Q for the quarter ended March 31, 2025, filed after the shut as we speak. This convention name additionally accommodates time-sensitive data that’s correct solely as of the date of this stay broadcast, Might 12, 2025. Relmada undertakes no obligation to revise or replace any forward-looking statements to replicate occasions or circumstances after the date of this convention name.
With me on as we speak’s name are Relmada’s